Continuous Bioprocessing Market Worth $429.12 million by 2028
Meticulous
Research®– a leading global market research company published a research report
titled “Continuous Bioprocessing Market by
Product (Filtration, Chromatography, Centrifuges, Consumables), Application
(Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User
(Pharmaceuticals, Biotechnology, CROs), and Geography - Forecast to
2028”.
Download
free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5079?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=20-02-2024
According
to this latest publication from Meticulous Research®, the continuous
bioprocessing market is expected to grow at a CAGR of 23.0% from $100.75
million in 2021 to $429.12 million by 2028. The growth in the overall
continuous bioprocessing market is mainly attributed to the growing demand for
biopharmaceuticals, growing development of new technologies and products
related to continuous bioprocessing, and rising government support for
biopharmaceutical manufacturing. In addition, significant opportunities from
emerging Asia-Pacific and Latin American regions and growing approval for
personalized medicines further support this market's growth. However, factors
such as the high risk of contamination with continuous bioprocessing, the
complex and technically unfeasible nature of continuous bioprocessing in
downstream processes, and shortage of bioprocessing professionals are expected
to hinder the adoption of continuous bioprocessing.
Continuous
Bioprocessing Market: Future Outlook
The
global continuous bioprocessing market study presents historical market data in
terms of values (2019 and 2020), estimated current data (2021), and forecasts
it for 2028– Product (Filtration, Chromatography, Centrifuges, Consumables),
Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User
(Pharmaceuticals, Biotechnology, CROs), and Geography. The study also evaluates
industry competitors and analyzes their market share at the global and regional
levels.
Based
on product, the filtration systems and
consumables segment accounted for the largest share of the market in 2020. The
growing demand for higher standards of filter operations in biopharma
manufacturing is one of the major drivers for the growth of this segment. Filter
manufacturers are developing filtration technologies for continuous
bioprocessing to achieve both separation and purification through a combination
of physical removal capabilities of filtration and size exclusion.
Based
on application, the research and development
segment is expected to grow at the highest CAGR during the forecast period. The
rising focus of R&D to develop vaccines and suitable therapies for COVID-19
and growing relevance of mAb manufacturing for the treatment of various
diseases are driving the market growth. The R&D in cell and gene therapy is
also accelerated, with over 900 candidates in clinical studies. Facility
expansions of CROs or CDMOs to advance research in these areas are expected to
boost market growth.
Speak to
analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5079?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=20-02-2024
Based
on end user, the CDMOs and CROs segment is
expected to grow at the highest CAGR during the forecast period. Rising
investments in CDMOs and CROs and the gradual shifting of CDMOs from batch to continuous
manufacturing are driving the market growth.
This
research report analyzes major geographies and provides comprehensive analysis
for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy,
Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC),
Latin America, and the Middle East & Africa. In 2020, North America
commanded the largest share of the global continuous bioprocessing market,
followed by Europe and Asia-Pacific. However, the Asia-Pacific region is
expected to grow at the highest CAGR during the forecast period.
The
key players operating in the continuous bioprocessing market are 3M (U.S.),
Cytiva (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany),
Sartorius AG (Germany), Repligen Corporation (U.S.), Eppendorf AG (Germany),
Applikon Biotechnology (Netherlands), Pall Corporation (U.S.), and Bionet
(Spain).
Key
questions answered in the report-
· What
are the high growth market segments in terms of product, application, end user,
and region/countries?
· What
was the historical market for continuous bioprocessing across the globe?
· What
are the market forecasts and estimates for the period 2021-2028?
· What
are the major drivers, restraints, challenges, opportunities, and trends in the
global continuous bioprocessing market?
· Who
are the major players in the global continuous bioprocessing market?
· How
is the competitive landscape, and who are the market leaders in the global
continuous bioprocessing market?
· What
are the recent developments in the global continuous bioprocessing market?
· What
are the different strategies adopted by the major players in the global
continuous bioprocessing market?
· What
are the geographical trends and high growth regions/countries?
Contact Us:
Meticulous
Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment